SCHEMBL1269926

SCHEMBL1269926

O=S(=O)(Nc1ccc(Sc2ccc(S(=O)(=O)N3CCCCC3)cc2)cn1)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ ATM Q13315 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SCN9A Q15858 3/20 0.44
▸ CCKBR P32239 1/20 0.44
▸ CCR6 P51684 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ GAA P10253 2/20 0.41
▸ PIK3C3 Q8NEB9 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ SCN5A Q14524 1/20 0.39
▸ TRPV4 Q9HBA0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12900168 0.91 GAA (0.48) SCN9ACCR6GAAPIK3C3SCN5A
SCHEMBL1269400 0.88 ALDH1A1 (0.47) ALDH1A1L3MBTL1MEN1TSHRKMT2A
SCHEMBL1269747 0.87 ALDH1A1 (0.42) ALDH1A1L3MBTL1ATMMEN1TSHR
SCHEMBL1269584 0.84 ALDH1A1 (0.43) ALDH1A1L3MBTL1ATMMEN1TSHR
SCHEMBL1269481 0.83 ALDH1A1 (0.43) ALDH1A1L3MBTL1ATMMEN1TSHR
SCHEMBL1268840 0.83 KDM4E (0.43) ALDH1A1L3MBTL1MEN1TSHRKMT2A
SCHEMBL1269628 0.82 CCKBR (0.43) ALDH1A1L3MBTL1ATMMEN1TSHR
SCHEMBL1268542 0.81 ALDH1A1 (0.42) ALDH1A1L3MBTL1ATMMEN1TSHR
SCHEMBL1269559 0.81 ALDH1A1 (0.38) ALDH1A1L3MBTL1ATMMEN1TSHR
SCHEMBL1269953 0.81 CCKBR (0.42) ALDH1A1L3MBTL1ATMMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
EP-1786782-A2 BISARYL-SULFONAMIDES Amgen Inc. (US) 2007-05-23 — — EP disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed
WO-2006020830-A2 BISARYL-SULFONAMIDES AMGEN INC. (US) 2006-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885L3MBTL1 3486/4885ATM 3485/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885L3MBTL1 3486/4885ATM 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback